Seattle, WA, United States of America

Charles G Cerveny

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 4.3

ph-index = 6

Forward Citations = 138(Granted Patents)


Company Filing History:


Years Active: 2011-2022

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Charles G Cerveny: Innovator in CD19 Binding Agents

Introduction

Charles G Cerveny is a prominent inventor based in Seattle, WA (US). He has made significant contributions to the field of biotechnology, particularly in the development of CD19 binding agents. With a total of 7 patents to his name, Cerveny's work has the potential to impact the treatment of various diseases.

Latest Patents

Cerveny's latest patents focus on CD19 binding agents and their applications. One of his notable inventions is related to CD19 binding agents and methods of using such agents for treating diseases. This innovation aims to provide new therapeutic options for patients suffering from conditions that can be targeted by these binding agents.

Career Highlights

Throughout his career, Cerveny has worked with several notable companies, including Seattle Genetics, Inc. and Emergent Product Development Seattle, LLC. His experience in these organizations has allowed him to refine his expertise in the development of innovative biotechnological solutions.

Collaborations

Cerveny has collaborated with talented individuals in his field, including Charlotte McDonagh and Dennis R Benjamin. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Charles G Cerveny is a distinguished inventor whose work in CD19 binding agents showcases his commitment to advancing medical science. His contributions have the potential to lead to significant improvements in disease treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…